Clinical Trials
- Endocrine System, Genetics
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (GATEWAY)
- Ages18 years - 60 years
- GenderBoth
- Endocrine System, Genetics
VX-121 Combination Therapy in Subjects With Cystic Fibrosis VX20-121-103
- Ages12 years and older
- GenderBoth
- Thyroid and Other Endocrine Cancers, Gynecological Cancers
Endometrium and Metabolism
- Children's Health, Endocrine System, Genetics, Mental Health & Behavioral Research
Yale Center for Clinical Investigation (YCCI) Specimen and Data Repository
- Ages7 years - 70 years
- GenderBoth
- Thyroid and Other Endocrine Cancers, Pancreatic Cancer
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
- Endocrine System
Sight-saving Engagement and Evaluation in New Haven (SEEN) Program
- Endocrine System
Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis
- Ages18 years - 80 years
- GenderBoth
- Kidney Cancer
A Phase 2 Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Advanced Non-Clear Cell Renal Cell Carcinoma
- Kidney Cancer
Phase II Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
- Kidney Cancer
A Phase 2, Randomized, Double-blind, Clinical Study of V940 (mRNA-4157) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in the Adjuvant Treatment of Participants With Renal Cell Carcinoma